A Phase I clinical trial of mosquito-borne disease vaccine AGS-v to evaluate safety in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 24 Feb 2017
At a glance
- Drugs AGS v (Primary)
- Indications Viral infections
- Focus Adverse reactions
- 24 Feb 2017 New trial record
- 21 Feb 2017 According to a Halloran Consulting Groups media release, enrollment is expected to complete by August 2017 and the study to complete around June 2018.